New drug achieves significant additional cholesterol-lowering in people with inherited high cholesterol on statins

2 octubre 2014

Evolocumab, an injected form of a new class of drugs called PCSK9 inhibitors, is highly effective at reducing low-density lipoprotein (LDL) or “bad cholesterol” levels with few side effects in people with familial hypercholesterolaemia (FH), an inherited condition that causes extremely high cholesterol and high risk of cardiovascular disease at an early age.